SMO Clinplus Co Ltd (301257)

Currency in CNY
50.18
+3.10(+6.58%)
Closed·
Unusual trading volume
301257 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
45.2051.20
52 wk Range
34.7585.00
Key Statistics
Bid/Ask
50.18 / 50.18
Prev. Close
47.08
Open
46
Day's Range
45.2-51.2
52 wk Range
34.75-85
Volume
8.14M
Average Volume (3m)
3.04M
1-Year Change
37.0289%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
301257 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.51
Downside
-45.18%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 27.51
(-45.18% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Apr 30, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.45%
Dividend Yield
0.31%
Industry Median 1.41%
Annualised payout
0.15
Paid annually
5-Years Growth
-
Growth Streak

301257 Income Statement

Compare 301257 to Peers and Sector

Metrics to compare
301257
Peers
Sector
Relationship
P/E Ratio
34.7x54.2x−0.4x
PEG Ratio
1.270.440.00
Price/Book
3.1x3.4x2.6x
Price / LTM Sales
4.6x5.8x3.0x
Upside (Analyst Target)
-6.3%51.7%
Fair Value Upside
Unlock26.7%8.8%Unlock

SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company offers early modeling, preliminary preparation plan trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China.

Employees
4526
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
14,83M18,78%744,40M
Other Institutional Investors
40,75M51,58%2,05B
Public Companies & Retail Investors
23,42M29,64%1,18B
Total
79M100,00%3,96B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Shihezi Xitai Equity Investment Partnership Enterprise (Limited Partnership)18,70%14 773 473741 333
Shanghai Xibao Investment Management Co., Ltd.18,70%14 773 473741 333

FAQ

What Is the SMO Clinplus (301257) Stock Price Today?

The SMO Clinplus stock price today is 50,18 CNY.

What Stock Exchange Does SMO Clinplus Trade On?

SMO Clinplus is listed and trades on the Shenzhen Stock Exchange.

What Is the Stock Symbol for SMO Clinplus?

The stock symbol for SMO Clinplus is "301257."

Does SMO Clinplus Pay Dividends? What’s The Current Dividend Yield?

The SMO Clinplus dividend yield is 0.31%.

What Is the SMO Clinplus Market Cap?

As of today, SMO Clinplus market cap is 3,96B CNY.

What Is SMO Clinplus's Earnings Per Share (TTM)?

The SMO Clinplus EPS (TTM) is 1,45.

When Is the Next SMO Clinplus Earnings Date?

SMO Clinplus will release its next earnings report on Aug 29, 2026.

From a Technical Analysis Perspective, Is 301257 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has SMO Clinplus Stock Split?

SMO Clinplus has split 1 times.

How Many Employees Does SMO Clinplus Have?

SMO Clinplus has 4526 employees.

What is the current trading status of SMO Clinplus (301257)?

As of Jul 12, 2026, SMO Clinplus (301257) is trading at a price of 50,18 CNY, with a previous close of 47,08 CNY. The stock has fluctuated within a day range of 45,20 CNY to 51,20 CNY, while its 52-week range spans from 34,75 CNY to 85,00 CNY.

What Is SMO Clinplus (301257) Price Target According to Analysts?

The average 12-month price target for SMO Clinplus is 27,51 CNY, with a high estimate of 27.51 CNY and a low estimate of 27.51 CNY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -45,18% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.